Log In
Print
BCIQ
Print
Print this Print this
 

SparVax (Recombinant protective antigen (rPA) anthrax vaccine)

  Manage Alerts
Collapse Summary General Information
Company PharmAthene Inc.
DescriptionSecond-generation recombinant protective antigen (rPA) anthrax vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAnthrax
Indication DetailsPrevent anthrax infection
Regulatory Designation

Partner

Medison Pharma Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today